Clinical Trial Update: The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating Adebrelimab in combination with a TP chemotherapy regimen as neoadjuvant therapy for stage IVB oral squamous cell carcinoma. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Hospital of Stomatology, Wuhan University | Conditions: Clinical IVb Stage Oral Squamous Cell Carcinomas Patients | Phase 2 | Status: RECRUITING